Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Absatz 8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sogenanntes Zulassungsmodell 2025-02“ der Deutschen Rentenversicherung Knappschaft-Bahn-See
Description
This notice serves to conclude agreements with pharmaceutical companies in accordance with Section 130a, paragraph 8, sentence 1 of the German Social Code, Book V (SGB V) (rebate contracts). According to Section 130a, paragraph 8, sentence 1 SGB V, the invitation to participate is only directed at pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs within the meaning of Section 4, paragraph 18 of the German Medicinal Products Act (AMG). This is not an open procedure, but a publication of the invitation to conclude/join rebate contracts with conditions fixed and non-negotiable for all participants, including the amount of the rebate. An unlimited number of pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs within the meaning of Section 4, paragraph 18 of the German Medicinal Products Act (AMG) can become contracting parties.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ponesimod, ATC L04AE04
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ebastin, ATC R06AX22
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026
Germany – Devices and instruments for infusion – Infusionstechnik Klinikum Oldenburg
Klinikum Oldenburg AöRGermanyDevices and instruments for infusionDeadline in 28 daysPublished on Sep 20, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Vaginalring mit Gestagenen und Estrogenen, ATC G02BB01
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026